178 related articles for article (PubMed ID: 9811141)
1. Ultrasmall superparamagnetic particles of iron oxide (USPIO) MR imaging of infarcted myocardium in pigs.
Kroft LJ; Doornbos J; van der Geest RJ; van der Laarse A; van der Meulen H; de Roos A
Magn Reson Imaging; 1998 Sep; 16(7):755-63. PubMed ID: 9811141
[TBL] [Abstract][Full Text] [Related]
2. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
[TBL] [Abstract][Full Text] [Related]
3. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
4. Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach.
Yilmaz A; Dengler MA; van der Kuip H; Yildiz H; Rösch S; Klumpp S; Klingel K; Kandolf R; Helluy X; Hiller KH; Jakob PM; Sechtem U
Eur Heart J; 2013 Feb; 34(6):462-75. PubMed ID: 23103659
[TBL] [Abstract][Full Text] [Related]
5. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: value of blood pool ultrasmall superparamagnetic particles of iron oxide.
Krombach GA; Wendland MF; Higgins CB; Saeed M
Radiology; 2002 Nov; 225(2):479-86. PubMed ID: 12409583
[TBL] [Abstract][Full Text] [Related]
7. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging.
Corot C; Petry KG; Trivedi R; Saleh A; Jonkmanns C; Le Bas JF; Blezer E; Rausch M; Brochet B; Foster-Gareau P; Balériaux D; Gaillard S; Dousset V
Invest Radiol; 2004 Oct; 39(10):619-25. PubMed ID: 15377941
[TBL] [Abstract][Full Text] [Related]
8. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of nonperfused myocardial ischemia with MRI and an intravascular USPIO contrast agent in an ex vivo pig model.
Bjerner T; Ericsson A; Wikström G; Johansson L; Nilsson S; Ahlström H; Hemmingsson A
J Magn Reson Imaging; 2000 Dec; 12(6):866-72. PubMed ID: 11105024
[TBL] [Abstract][Full Text] [Related]
10. Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice.
Desestret V; Brisset JC; Moucharrafie S; Devillard E; Nataf S; Honnorat J; Nighoghossian N; Berthezène Y; Wiart M
Stroke; 2009 May; 40(5):1834-41. PubMed ID: 19286601
[TBL] [Abstract][Full Text] [Related]
11. Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms.
Laghi A; Paolantonio P; Panebianco V; Miglio C; Iafrate F; Di Tondo U; Passariello R
Invest Radiol; 2004 Nov; 39(11):666-70. PubMed ID: 15486527
[TBL] [Abstract][Full Text] [Related]
12. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
[TBL] [Abstract][Full Text] [Related]
13. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection.
Panting JR; Taylor AM; Gatehouse PD; Keegan J; Yang GZ; McGill S; Francis JM; Burman ED; Firmin DN; Pennell DJ
J Magn Reson Imaging; 1999 Sep; 10(3):404-10. PubMed ID: 10508302
[TBL] [Abstract][Full Text] [Related]
14. High in-plane resolution T2-weighted magnetic resonance imaging of acute myocardial ischemia in pigs using the intravascular contrast agent NC100150 injection.
Bjerner T; Wikström G; Johansson L; Ahlström H
Invest Radiol; 2004 Aug; 39(8):470-8. PubMed ID: 15257208
[TBL] [Abstract][Full Text] [Related]
15. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents.
Reimer P; Kwong KK; Weisskoff R; Cohen MS; Brady TJ; Weissleder R
J Magn Reson Imaging; 1992; 2(2):177-81. PubMed ID: 1562768
[TBL] [Abstract][Full Text] [Related]
16. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats.
Kaim AH; Wischer T; O'Reilly T; Jundt G; Fröhlich J; von Schulthess GK; Allegrini PR
Radiology; 2002 Dec; 225(3):808-14. PubMed ID: 12461265
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging.
Senéterre E; Weissleder R; Jaramillo D; Reimer P; Lee AS; Brady TJ; Wittenberg J
Radiology; 1991 May; 179(2):529-33. PubMed ID: 2014305
[TBL] [Abstract][Full Text] [Related]
18. Extra- and intracellular accumulation of ultrasmall superparamagnetic iron oxides (USPIO) in experimentally induced abscesses of the peripheral soft tissues and their effects on magnetic resonance imaging.
Gellissen J; Axmann Ch; Prescher A; Bohndorf K; Lodemann KP
Magn Reson Imaging; 1999 May; 17(4):557-67. PubMed ID: 10231182
[TBL] [Abstract][Full Text] [Related]
19. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.
Metz S; Bonaterra G; Rudelius M; Settles M; Rummeny EJ; Daldrup-Link HE
Eur Radiol; 2004 Oct; 14(10):1851-8. PubMed ID: 15249981
[TBL] [Abstract][Full Text] [Related]
20. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
